{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:09:11Z","timestamp":1789373351006,"version":"build-2803163510"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100023699","name":"Health Data Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023233","name":"National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023233","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Policy Research Programme"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Progn Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Monitoring trends in repeated blood tests might offer opportunities to improve cancer detection. This review aimed to systematically map the existing literature on blood test trends in cancer detection, characterise how these trends have been used in cancer detection approaches, and identify research gaps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEDLINE, Embase, ProQuest Dissertations &amp; Theses Global, and Overton were searched from inception to April 2025 to identify published and unpublished studies investigating pre-diagnostic blood test trends for cancer detection. Screening was performed by four reviewers. Data extraction was conducted independently by two reviewers, with discrepancies resolved through consensus. Data were narratively synthesised to summarise study and patient characteristics, and the blood tests and cancers investigated. Major themes were identified to categorise key research areas and describe how blood test trends have been used in cancer detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ninety studies were included. Colorectal and pancreatic cancers were the most commonly studied cancers, with haemoglobin and HbA1c the most frequently investigated blood tests for each, respectively. Studies primarily focused on either the association between blood test trends and cancer (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200964) or on prediction models incorporating blood test trends to predict cancer risk (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926). Additional thematic areas covered by the included studies were: combining trends with other risk factors for cancer (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200962), implication for practice (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200958), blood tests trends versus abnormality (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940), combination of trends in different blood tests (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200939), and bias due to informative observation (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912). However, evidence for many other cancer types was scarce, and important gaps remain in understanding how blood test trends can be further used for cancer detection, including their predictive value and implementation strategies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Evidence to date indicates that blood test trends have been increasingly studied in the context of cancer detection, although knowledge remains fragmented and largely exploratory. Future research should expand to under-studied cancers and examine these trends across a broader range of contexts to better understand their role in cancer detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Registration<\/jats:title>\n                    <jats:p>\n                      Open Science Framework\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/osf.io\/ue8s4\" ext-link-type=\"uri\">https:\/\/osf.io\/ue8s4<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41512-026-00236-9","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:16:51Z","timestamp":1789366611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The use of blood test trends in cancer detection: a scoping review"],"prefix":"10.1186","volume":"10","author":[{"given":"Sufen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Friedemann Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiana K.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheba E.","family":"Ziyenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"de Vere Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Brubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nia","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva J.A.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep S.","family":"Virdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"236_CR1","unstructured":"Cancer Research UK. Cancer mortality statistics [cited 2023 Nov 8]. Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/mortality."},{"key":"236_CR2","unstructured":"World Health Organization. Cancer [cited 2023 Nov 8]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"236_CR3","unstructured":"Cancer survival by stage at diagnosis for England (experimental statistics): Adults diagnosed 2012, 2013 and 2014 and followed up to 2015 [cited 2023 Nov 8]. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/cancersurvivalbystageatdiagnosisforenglandexperimentalstatistics\/adultsdiagnosed20122013and2014andfollowedupto2015."},{"key":"236_CR4","unstructured":"Cancer Research UK. Cancer screening and diagnosis [cited 2023 Nov 8]. Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics-for-the-uk#heading-Four"},{"issue":"1","key":"236_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrclinonc.2013.212","volume":"11","author":"JD Emery","year":"2014","unstructured":"Emery JD, Shaw K, Williams B, Mazza D, Fallon-Ferguson J, Varlow M, et al. The role of primary care in early detection and follow-up of cancer. Nat Reviews Clin Oncol. 2014;11(1):38\u201348.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"12","key":"236_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S1470-2045(15)00205-3","volume":"16","author":"G Rubin","year":"2015","unstructured":"Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16(12):1231\u201372.","journal-title":"Lancet Oncol"},{"issue":"592","key":"236_CR7","doi-asserted-by":"publisher","first-page":"e715","DOI":"10.3399\/bjgp11X606627","volume":"61","author":"J Hippisley-Cox","year":"2011","unstructured":"Hippisley-Cox J, Coupland C. Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract. 2011;61(592):e715\u201323.","journal-title":"Br J Gen Pract"},{"issue":"2","key":"236_CR8","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1038\/sj.bjc.6605396","volume":"101","author":"W Hamilton","year":"2009","unstructured":"Hamilton W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009;101(2):S80\u20136.","journal-title":"Br J Cancer"},{"key":"236_CR9","doi-asserted-by":"publisher","first-page":"g7400","DOI":"10.1136\/bmj.g7400","volume":"349","author":"L Georgios","year":"2014","unstructured":"Georgios L, Jane W, Greg R. Rethinking diagnostic delay in cancer: how difficult is the diagnosis? BMJ. BMJ. 2014;349:g7400.","journal-title":"BMJ"},{"key":"236_CR10","first-page":"l5774","volume":"367","author":"W Jessica","year":"2019","unstructured":"Jessica W, Luke M, Sarah ERB, Sharon LC, Willie H. Blood markers for cancer. BMJ. 2019;367:l5774.","journal-title":"BMJ"},{"key":"236_CR11","unstructured":"National Institute for Health and Care Excellence. Suspected cancer: recognition and referral (NG12) [cited 2023 Nov 8]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng12"},{"issue":"28","key":"236_CR12","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1002\/sim.7144","volume":"36","author":"MJ Sweeting","year":"2017","unstructured":"Sweeting MJ, Barrett JK, Thompson SG, Wood AM. The use of repeated blood pressure measures for cardiovascular risk prediction: a comparison of statistical models in the ARIC study. Stat Med. 2017;36(28):4514\u201328.","journal-title":"Stat Med"},{"issue":"2","key":"236_CR13","doi-asserted-by":"publisher","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","volume":"10","author":"EW Steyerberg","year":"2013","unstructured":"Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10(2):e1001381.","journal-title":"PLoS Med"},{"key":"236_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41512-018-0024-7","volume":"2","author":"M Welten","year":"2018","unstructured":"Welten M, de Kroon MLA, Renders CM, Steyerberg EW, Raat H, Twisk JWR, et al. Repeatedly measured predictors: a comparison of methods for prediction modeling. Diagn Progn Res. 2018;2:5.","journal-title":"Diagn Progn Res"},{"issue":"17","key":"236_CR15","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1002\/sim.7308","volume":"36","author":"BA Goldstein","year":"2017","unstructured":"Goldstein BA, Pomann GM, Winkelmayer WC, Pencina MJ. A comparison of risk prediction methods using repeated observations: an application to electronic health records for hemodialysis. Stat Med. 2017;36(17):2750\u201363.","journal-title":"Stat Med"},{"issue":"1","key":"236_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/jamia\/ocw042","volume":"24","author":"BA Goldstein","year":"2017","unstructured":"Goldstein BA, Navar AM, Pencina MJ, Ioannidis JP. Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review. J Am Med Inf Assoc. 2017;24(1):198\u2013208.","journal-title":"J Am Med Inf Assoc"},{"issue":"9","key":"236_CR17","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.3390\/cancers16091692","volume":"16","author":"PS Virdee","year":"2024","unstructured":"Virdee PS, Collins KK, Friedemann Smith C, Yang X, Zhu S, Roberts SE, et al. The Association between Blood Test Trends and Undiagnosed Cancer: A Systematic Review and Critical Appraisal. Cancers. 2024;16(9):1692.","journal-title":"Cancers"},{"issue":"7","key":"236_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"236_CR19","doi-asserted-by":"crossref","unstructured":"Holt TA, Virdee PS, Bankhead C, Patnick J, Nicholson BD, Fuller A, et al. Early detection of colorectal cancer using symptoms and the ColonFlag: case-control and cohort studies [version 1; peer review: 2 approved with reservations]. NIHR Open Res. 2023;3:6.","DOI":"10.3310\/nihropenres.13360.1"},{"key":"236_CR20","doi-asserted-by":"publisher","first-page":"S1061","DOI":"10.14309\/00000434-201610001-02214","volume":"111","author":"A Adiga","year":"2016","unstructured":"Adiga A, Mohamed A, Edriss H, Nugent K. Unusual presentation of gastrointestinal non hodgkin lymphoma. Am J Gastroenterol. 2016;111:S1061\u20132.","journal-title":"Am J Gastroenterol"},{"key":"236_CR21","doi-asserted-by":"crossref","unstructured":"Alcala K, Zahed H, Cortez Cardoso Penha R, Alcala N, Robbins HA, Smith-Byrne K, et al. Kidney Function and Risk of Renal Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 2023;32(11):1644\u201350.","DOI":"10.1158\/1055-9965.EPI-23-0558"},{"key":"236_CR22","unstructured":"Andersen MA, Grand MK, Siersma V, Olivarius N, Andersen CL, Niemann CU. Prediagnostic progression of lymphocytosis in chronic lymphocytic leukemia is predictive of progression free survival as early as five years prior to diagnosis. Blood. 2017;130:1726."},{"issue":"Suppl 2","key":"236_CR23","doi-asserted-by":"publisher","first-page":"s99","DOI":"10.7861\/clinmed.20-2-s99","volume":"20","author":"C Atkin","year":"2020","unstructured":"Atkin C, Sapey E, Richter A, Ayling RM, Lewis SJ, Cotter F. Change in blood test results prior to diagnosis in multiple myeloma Potential roles of artificial intelligence learning and faecal immunochemical testing for prioritisation of colonoscopy in anaemia. Clin Med. 2020;20(Suppl 2):s99\u2013100.","journal-title":"Clin Med"},{"issue":"1","key":"236_CR24","first-page":"8","volume":"70","author":"OSE Bakheet","year":"2016","unstructured":"Bakheet OSE, Fun LC, Ithnin A, Wahid SFA. IgD-kappa multiple myeloma. Case report and brief review of the literature. New Z J Med Lab Sci. 2016;70(1):8\u201311.","journal-title":"New Z J Med Lab Sci"},{"key":"236_CR25","unstructured":"Barlow M, Pula G, Hamilton W, Bailey S. Platelet count as a novel diagnostic marker for early lung cancer diagnosis: an epidemiological study. Res Pract Thromb Haemost. 2022;6:458."},{"issue":"6","key":"236_CR26","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(21)01834-5","volume":"160","author":"MJ Brewer","year":"2021","unstructured":"Brewer MJ, Doucette J, Bar-Mashiah A, Glickman JW, Aronson A, Kessel E, et al. Hemoglobin A1c Elevation And Weight Loss Precede Pancreatic Cancer Up To 3 Years Before Diagnosis In A Diverse Population. Gastroenterology. 2021;160(6):S\u2013473.","journal-title":"Gastroenterology"},{"issue":"5","key":"236_CR27","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/0016-5085(92)91194-9","volume":"103","author":"PJ Capizzi","year":"1992","unstructured":"Capizzi PJ, Rosen CB, Nagorney DM. Intermittent jaundice by tumor emboli from intrahepatic cholangiocarcinoma. Gastroenterology. 1992;103(5):1669\u201373.","journal-title":"Gastroenterology"},{"issue":"3","key":"236_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/hon.2992","volume":"40","author":"MA Casta\u00f1eda-Avila","year":"2022","unstructured":"Casta\u00f1eda-Avila MA, Lapane KL, Person SD, Zhou Y, Gurwitz J, Mazor KM, et al. Multi-trajectory models of serum biomarkers among patients with monoclonal gammopathy of undetermined significance. Hematol Oncol. 2022;40(3):409\u201316.","journal-title":"Hematol Oncol"},{"issue":"16","key":"236_CR29","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1200\/JCO.2009.27.0454","volume":"28","author":"AK Chaturvedi","year":"2010","unstructured":"Chaturvedi AK, Caporaso NE, Katki HA, Wong HL, Chatterjee N, Pine SR, et al. C-reactive protein and risk of lung cancer. J Clin Oncol. 2010;28(16):2719\u201326.","journal-title":"J Clin Oncol"},{"issue":"8","key":"236_CR30","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.pan.2019.10.002","volume":"19","author":"J de la Fuente","year":"2019","unstructured":"de la Fuente J, Sharma A, Chari S, Majumder S. Peripheral blood monocyte counts are elevated in the pre-diagnostic phase of pancreatic cancer: A population based study. Pancreatology. 2019;19(8):1043\u20138.","journal-title":"Pancreatology"},{"issue":"6","key":"236_CR31","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/ijc.25122","volume":"127","author":"G Edgren","year":"2010","unstructured":"Edgren G, Bagnardi V, Bellocco R, Hjalgrim H, Rostgaard K, Melbye M, et al. Pattern of declining hemoglobin concentration before cancer diagnosis. Int J Cancer. 2010;127(6):1429\u201336.","journal-title":"Int J Cancer"},{"issue":"4","key":"236_CR32","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/ijc.32858","volume":"147","author":"X Feng","year":"2020","unstructured":"Feng X, Wang G, Lyu Z, Chen S, Wei L, Li X, et al. The association between fasting blood glucose trajectory and cancer risk in Chinese population without diabetes. Int J Cancer. 2020;147(4):958\u201366.","journal-title":"Int J Cancer"},{"key":"236_CR33","volume-title":"Acute phase reactants prior to diagnosis of cancer or myocardial infarction","author":"JL Fisher Jr","year":"1999","unstructured":"Fisher JL Jr., Schwartzbaum J. Acute phase reactants prior to diagnosis of cancer or myocardial infarction. United States -- Ohio: The Ohio State University; 1999."},{"issue":"6","key":"236_CR34","first-page":"327","volume":"5","author":"R Furukawa","year":"1984","unstructured":"Furukawa R, Tajima H, Nakata K, Kono K, Muro T, Sato A, et al. Clinical significance of serum alpha-fetoprotein in patients with liver cirrhosis. Tumour Biol. 1984;5(6):327\u201338.","journal-title":"Tumour Biol"},{"issue":"1","key":"236_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/SMJ.0b013e3181fcd4b9","volume":"104","author":"A Garg","year":"2011","unstructured":"Garg A, Hosfield EM, Brickner L. Disseminated intravascular large B cell lymphoma with slowly decreasing high-density lipoprotein cholesterol. South Med J. 2011;104(1):53\u20136.","journal-title":"South Med J"},{"issue":"6","key":"236_CR36","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(19)36875-1","volume":"156","author":"SK Garg","year":"2019","unstructured":"Garg SK, Singh DP, Sharma A, Kandlakunta H, Nagpal SJS, Chari ST. GLYCEMIC PROFILE OF SUBJECTS WITH FAMILIAL PANCREATIC CANCER: MAYO CLINIC EXPERIENCE FROM 2000\u20132018. Gastroenterology. 2019;156(6):S\u201338.","journal-title":"Gastroenterology"},{"key":"236_CR37","doi-asserted-by":"crossref","unstructured":"Giannakeas V, Kotsopoulos J, Narod S. 1131\u2005Leveraging electronic medical records and machine learning for early detection of ovarian cancer. Int J Gynecol Cancer. 2024;34:A404\u2013A5.","DOI":"10.1136\/ijgc-2024-ESGO.793"},{"key":"236_CR38","volume-title":"The Association of Platelet Count on Cancer Incidence and Survival","author":"V Giannakeas","year":"2022","unstructured":"Giannakeas V, Narod SA. The Association of Platelet Count on Cancer Incidence and Survival. Canada -- Ontario, CA: University of Toronto (Canada); 2022."},{"issue":"5","key":"236_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/CEJ.0b013e32833c1be0","volume":"19","author":"I Goldshtein","year":"2010","unstructured":"Goldshtein I, Neeman U, Chodick G, Shalev V. Variations in hemoglobin before colorectal cancer diagnosis. Eur J Cancer Prev. 2010;19(5):342\u20134.","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"236_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12885-020-06754-z","volume":"20","author":"KO Gradel","year":"2020","unstructured":"Gradel KO, Povoa P, Garvik OS, Vinholt PJ, Nielsen SL, Jensen TG, et al. Longitudinal trajectory patterns of plasma albumin and C-reactive protein levels around diagnosis, relapse, bacteraemia, and death of acute myeloid leukaemia patients. BMC Cancer. 2020;20(1):249.","journal-title":"BMC Cancer"},{"issue":"8","key":"236_CR41","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.mayocp.2019.01.041","volume":"94","author":"RW Hsieh","year":"2019","unstructured":"Hsieh RW, Ravindran A, Hook CC, Begna KH, Ashrani AA, Pruthi RK, et al. Etiologies of Extreme Thrombocytosis: A Contemporary Series. Mayo Clin Proc. 2019;94(8):1542\u201350.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"236_CR42","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.cgh.2019.11.043","volume":"18","author":"BZ Huang","year":"2020","unstructured":"Huang BZ, Pandol SJ, Jeon CY, Chari ST, Sugar CA, Chao CR, et al. New-Onset Diabetes, Longitudinal Trends in Metabolic Markers, and Risk of Pancreatic Cancer in a Heterogeneous Population. Clin Gastroenterol Hepatol. 2020;18(8):1812.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"236_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1365-2796.1996.30195852000.x","volume":"240","author":"OH Iversen","year":"1996","unstructured":"Iversen OH, Roger M, Solberg HE, Wetteland P. Rising erythrocyte sedimentation rate during several years before diagnosis can be a predictive factor in 70% of renal cell carcinoma patients. The benefit of knowing subject-based reference values. J Intern Med. 1996;240(3):133\u201341.","journal-title":"J Intern Med"},{"key":"236_CR44","first-page":"15","volume":"15","author":"S Jacobson","year":"2021","unstructured":"Jacobson S, Dahlqvist P, Johansson M, Svensson J, Billing O, Sund M, et al. Hyperglycemia as a risk factor in pancreatic cancer: A nested case-control study using prediagnostic blood glucose levels. Pancreatology. 2021;15:15.","journal-title":"Pancreatology"},{"issue":"11","key":"236_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12113349","volume":"12","author":"P Jonsson","year":"2020","unstructured":"Jonsson P, Antti H, Spath F, Melin B, Bjorkblom B. Identification of pre-diagnostic metabolic patterns for glioma using subset analysis of matched repeated time points. Cancers. 2020;12(11):1\u201320.","journal-title":"Cancers"},{"key":"236_CR46","first-page":"1364A","volume":"54","author":"Y Kawamura","year":"2011","unstructured":"Kawamura Y, Arase Y, Ikeda K, Seko Y, Imai N, Hosaka T, et al. Prolonged new onset of hepatocellular carcinoma from non-alcoholic fatty liver disease in Japanese large population. Hepatology. 2011;54:1364A.","journal-title":"Hepatology"},{"key":"236_CR47","doi-asserted-by":"crossref","first-page":"A1006","DOI":"10.1002\/hep.29334","volume":"66","author":"J Kim","year":"2017","unstructured":"Kim J, Jo W, Sinn DH, Kang W, Gwak GY, Paik YH, et al. A dynamic change in albumin-bilirubin grade can effectively stratify patient\u2019s risk for developing hepatocellular carcinoma for patients treated with entecavir. Hepatology. 2017;66:A1006\u20137.","journal-title":"Hepatology"},{"key":"236_CR48","doi-asserted-by":"crossref","unstructured":"Klatte DCF, Weston A, Ma Y, Sledge H, Bali A, Bolan C, et al. Temporal trends in body composition and metabolic markers prior to diagnosis of pancreatic ductal adenocarcinoma. Clinical Gastroenterology and Hepatology; 2024.","DOI":"10.1016\/j.cgh.2024.03.038"},{"issue":"674","key":"236_CR49","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.3399\/bjgp18X698357","volume":"68","author":"C Koshiaris","year":"2018","unstructured":"Koshiaris C, Van den Bruel A, Oke JL, Nicholson BD, Shephard E, Braddick M, et al. Early detection of multiple myeloma in primary care using blood tests: a case-control study in primary care. Br J Gen Pract. 2018;68(674):e586\u201393.","journal-title":"Br J Gen Pract"},{"issue":"6","key":"236_CR50","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00595-015-1229-9","volume":"46","author":"S Kubo","year":"2016","unstructured":"Kubo S, Takemura S, Tanaka S, Nishioka T, Kinoshita M, Hamano G, et al. Screening and surveillance for occupational cholangiocarcinoma in workers exposed to organic solvents. Surg Today. 2016;46(6):705\u201312.","journal-title":"Surg Today"},{"issue":"10","key":"236_CR51","doi-asserted-by":"publisher","first-page":"e0275369","DOI":"10.1371\/journal.pone.0275369","volume":"17","author":"A Lemanska","year":"2022","unstructured":"Lemanska A, Price CA, Jeffreys N, Byford R, Dambha-Miller H, Fan X, et al. BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database. PLoS ONE. 2022;17(10):e0275369.","journal-title":"PLoS ONE"},{"issue":"3","key":"236_CR52","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/00365521.2021.1879245","volume":"56","author":"M Li","year":"2021","unstructured":"Li M, Cao Y, Olsson L. A population-based study on time trends of hemoglobin in primary care comparing prediagnostic colorectal cancer patients vs age- and sex-matched controls. Scand J Gastroenterol. 2021;56(3):266\u201373.","journal-title":"Scand J Gastroenterol"},{"key":"236_CR53","doi-asserted-by":"publisher","first-page":"i59","DOI":"10.1093\/clinchem\/hvad097.148","volume":"69","author":"NJ Mathewson","year":"2023","unstructured":"Mathewson NJ, Pearson LN, Doyle K. Abnormal HbA1c Results Lead to an Unexpected Chronic Myeloid Leukemia Diagnosis. Clin Chem. 2023;69:i59.","journal-title":"Clin Chem"},{"key":"236_CR54","doi-asserted-by":"crossref","first-page":"A126","DOI":"10.1136\/gut.2009.179523","volume":"59","author":"IJA McCaughan","year":"2010","unstructured":"McCaughan IJA, Hoeritzauer, Lynch P, Varghese A. Missing colorectal cancer: The muddle of haemoglobin, Ferritin and MCV. Gut. 2010;59:A126\u20137.","journal-title":"Gut"},{"issue":"4","key":"236_CR55","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.pan.2019.03.006","volume":"19","author":"AM Mueller","year":"2019","unstructured":"Mueller AM, Meier CR, Jick SS, Schneider C. Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study. Pancreatology. 2019;19(4):578\u201386.","journal-title":"Pancreatology"},{"issue":"4","key":"236_CR56","first-page":"e896","volume":"197","author":"T Murtola","year":"2017","unstructured":"Murtola T, Vihervuori V, Talala K, Taari K, Tammela T, Auvinen A. Fasting blood glucose and prostate cancer risk in the finnish randomized study of screening for prostate cancer. J Urol. 2017;197(4):e896\u20137.","journal-title":"J Urol"},{"key":"236_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1158\/1538-7445.AM2019-3316","volume":"79","author":"L Oba","year":"2019","unstructured":"Oba L, Loud JT, Achatz MI, Savage SA, Khincha PP. Screening blood tests and cancer detection in Li-Fraumeni syndrome. Cancer Res. 2019;79:13.","journal-title":"Cancer Res"},{"issue":"9","key":"236_CR58","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/ajg.2009.253","volume":"104","author":"R Pannala","year":"2009","unstructured":"Pannala R, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, et al. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol. 2009;104(9):2318\u201325.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"236_CR59","doi-asserted-by":"publisher","first-page":"dju097","DOI":"10.1093\/jnci\/dju097","volume":"106","author":"S Rinaldi","year":"2014","unstructured":"Rinaldi S, Plummer M, Biessy C, Tsilidis KK, Ostergaard JN, Overvad K, et al. Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst. 2014;106(6):dju097.","journal-title":"J Natl Cancer Inst"},{"key":"236_CR60","doi-asserted-by":"publisher","first-page":"EP141","DOI":"10.1016\/j.ejim.2024.02.033","volume":"124","author":"A Rotkopf","year":"2024","unstructured":"Rotkopf A, Giladi E, Elis A. HbA1c% level patterns as a marker for malignancy in diabetic patients. Eur J Intern Med. 2024;124:EP141\u20132.","journal-title":"Eur J Intern Med"},{"key":"236_CR61","doi-asserted-by":"crossref","first-page":"S502","DOI":"10.1007\/s11606-022-07902-w","volume":"38","author":"T Ryan","year":"2023","unstructured":"Ryan T, Korapati S, Shukla P, Nandi M. NEUROENDOCRINE TUMOR DISGUISED AS UNCONTROLLED DIABETES. J Gen Intern Med. 2023;38:S502\u20133.","journal-title":"J Gen Intern Med"},{"issue":"7","key":"236_CR62","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3109\/0284186X.2015.1006402","volume":"54","author":"O Sadr-Azodi","year":"2015","unstructured":"Sadr-Azodi O, Gudbjornsdottir S, Ljung R. Pattern of increasing HbA1c levels in patients with diabetes mellitus before clinical detection of pancreatic cancer - a population-based nationwide case-control study. Acta Oncol. 2015;54(7):986\u201392.","journal-title":"Acta Oncol"},{"issue":"5","key":"236_CR63","doi-asserted-by":"publisher","first-page":"S491","DOI":"10.1016\/S0016-5085(17)31822-X","volume":"152","author":"RP Sah","year":"2017","unstructured":"Sah RP, Nagpal SJS, Sharma A, Kamboj AK, Takahashi N, Mukhopadhyay D, et al. Paraneoplastic weight loss and rise in blood glucose preceding symptoms of pancreatic cancer (PC): Opportunity for early detection. Gastroenterology. 2017;152(5):S491.","journal-title":"Gastroenterology"},{"issue":"20","key":"236_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/jcm12206540","volume":"12","author":"RJ Sala","year":"2023","unstructured":"Sala RJ, Ery J, Cuesta-Peredo D, Muedra V, Rodilla V. Complete Blood Count Alterations Prior to the Diagnosis of Colorectal Cancer May Help in the Detection of Synchronous Liver Metastases. J Clin Med. 2023;12(20):15.","journal-title":"J Clin Med"},{"key":"236_CR65","doi-asserted-by":"crossref","unstructured":"Sanchez-Salcedo P, de-Torres JP, Martinez-Urbistondo D, Gonzalez-Gutierrez J, Berto J, Campo A, et al. The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development. Lung Cancer. 2016;97:28\u201334.","DOI":"10.1016\/j.lungcan.2016.04.010"},{"issue":"7","key":"236_CR66","first-page":"1147","volume":"41","author":"E Sato","year":"2012","unstructured":"Sato E, Tando Y, Yanagimachi M, Tanaka H, Matsugashi Y, Matsumto A, et al. How should we treat glucose intolerance as a risk factor for pancreatic cancer? Pancreas. 2012;41(7):1147.","journal-title":"Pancreas"},{"issue":"4","key":"236_CR67","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.pan.2016.06.430","volume":"16","author":"E Sato","year":"2016","unstructured":"Sato E, Tando Y, Yanagimachi M, Tanaka H, Matsuhashi Y, Matsumoto A, et al. The characteristics of diabetic patients preceding the diagnosis of pancreatic cancer. Pancreatology. 2016;16(4):S119\u201320.","journal-title":"Pancreatology"},{"issue":"6","key":"236_CR68","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/CEJ.0000000000000397","volume":"27","author":"C Schneider","year":"2018","unstructured":"Schneider C, Bodmer M, Jick SS, Meier CR. Colorectal cancer and markers of anemia. Eur J Cancer Prev. 2018;27(6):530\u20138.","journal-title":"Eur J Cancer Prev"},{"key":"236_CR69","doi-asserted-by":"publisher","first-page":"S398","DOI":"10.1016\/j.annonc.2022.04.057","volume":"33","author":"G Schwartz","year":"2022","unstructured":"Schwartz G, Lutz D, Bell M, Klug M. 39P Longitudinal increases in albumin-adjusted serum calcium predict ovarian cancer. Ann Oncol. 2022;33:S398\u20139.","journal-title":"Ann Oncol"},{"issue":"10","key":"236_CR70","first-page":"1422","volume":"47","author":"A Sharma","year":"2018","unstructured":"Sharma A, Chari ST, Majumder S. Pancreatic ductal adenocarcinoma is associated with elevated peripheral blood monocyte counts. Pancreas. 2018;47(10):1422\u20133.","journal-title":"Pancreas"},{"issue":"2","key":"236_CR71","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1053\/j.gastro.2018.04.025","volume":"155","author":"A Sharma","year":"2018","unstructured":"Sharma A, Smyrk TC, Levy MJ, Topazian MA, Chari ST. Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis. Gastroenterology. 2018;155(2):490\u2013e5002.","journal-title":"Gastroenterology"},{"issue":"8","key":"236_CR72","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1097\/MPH.0000000000000899","volume":"39","author":"H Shaukat","year":"2017","unstructured":"Shaukat H, O\u2019Mara J, Neier M. A Pediatric Case of Persistent Thrombocytopenia in a Patient Who Developed All. J Pediatr Hematol Oncol. 2017;39(8):e512\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"key":"236_CR73","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1182\/blood-2021-151802","volume":"138","author":"M Shukla","year":"2021","unstructured":"Shukla M, Rivero GA. Impaired left ventricular ejection fraction induces \u2018very early pre-diagnostic\u2019 hemopoietic modifications in myeloid leukemia patients. Blood. 2021;138:3375.","journal-title":"Blood"},{"issue":"6","key":"236_CR74","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1158\/1055-9965.EPI-23-1145","volume":"33","author":"M Song","year":"2024","unstructured":"Song M, Graubard BI, Loftfield E, Rabkin CS, Engels EA. White Blood Cell Count, Neutrophil-to-Lymphocyte Ratio, and Incident Cancer in the UK Biobank. Cancer Epidemiol Biomarkers Prev. 2024;33(6):821\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"236_CR75","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.soard.2020.04.012","volume":"16","author":"AM Stroud","year":"2020","unstructured":"Stroud AM, Dewey EN, Husain FA, Fischer JM, Courcoulas AP, Flum DR, et al. Association between weight loss and serum biomarkers with risk of incident cancer in the Longitudinal Assessment of Bariatric Surgery cohort. Surg Obes Relat Dis. 2020;16(8):1086\u201394.","journal-title":"Surg Obes Relat Dis"},{"key":"236_CR76","doi-asserted-by":"publisher","first-page":"A769","DOI":"10.1210\/jendso\/bvaa046.1518","volume":"4","author":"J Suarez","year":"2020","unstructured":"Suarez J. Pancreatic Cancer in Longstanding Diabetes. J Endocr Soc. 2020;4:A769.","journal-title":"J Endocr Soc"},{"issue":"3","key":"236_CR77","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/gutjnl-2021-326522","volume":"72","author":"PS Tan","year":"2023","unstructured":"Tan PS, Garriga C, Clift A, Liao W, Patone M, Coupland C, et al. Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study. Gut. 2023;72(3):512\u201321.","journal-title":"Gut"},{"key":"236_CR78","first-page":"528A","volume":"68","author":"R Tateishi","year":"2018","unstructured":"Tateishi R, Matsumura T, Uchino K, Fujiwara N, Senokuchi T, Kon K, et al. Hepatocellular carcinoma development in patients with diabetes mellitus: A nationwide case-control study. Hepatology. 2018;68:528A.","journal-title":"Hepatology"},{"issue":"11","key":"236_CR79","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1002\/ijc.27942","volume":"132","author":"AT Toriola","year":"2013","unstructured":"Toriola AT, Cheng TY, Neuhouser ML, Wener MH, Zheng Y, Brown E, et al. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer. 2013;132(11):2648\u201358.","journal-title":"Int J Cancer"},{"issue":"8","key":"236_CR80","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/annonc\/mdq694","volume":"22","author":"AT Toriola","year":"2011","unstructured":"Toriola AT, Grankvist K, Agborsangaya CB, Lukanova A, Lehtinen M, Surcel HM. Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study. Ann Oncol. 2011;22(8):1916\u201321.","journal-title":"Ann Oncol"},{"issue":"32","key":"236_CR81","first-page":"1","volume":"2","author":"PS Virdee","year":"2022","unstructured":"Virdee PS, Patnick J, Watkinson P, Birks J, Holt TA. Trends in the full blood count blood test and colorectal cancer detection: a longitudinal, case-control study of UK primary care patient data. NIHR Open Res. 2022;2(32):1\u201362.","journal-title":"NIHR Open Res"},{"issue":"7","key":"236_CR82","doi-asserted-by":"publisher","first-page":"A437","DOI":"10.1016\/j.jval.2015.09.1060","volume":"18","author":"MM Zanders","year":"2015","unstructured":"Zanders MM, Van Herk-Sukel MP, Herings RM, Van De Poll-Franse LV, Haak H. Impact of cancer diagnosis and treatment on glycaemic control among individuals with colorectal cancer using glucose lowering drugs. Value Health. 2015;18(7):A437.","journal-title":"Value Health"},{"issue":"2","key":"236_CR83","doi-asserted-by":"publisher","first-page":"99349","DOI":"10.3748\/wjg.v31.i2.99349","volume":"31","author":"WC Zhen","year":"2025","unstructured":"Zhen WC, Sun J, Bai XT, Zhang Q, Li ZH, Zhang YX, et al. Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma development. World J Gastroenterol. 2025;31(2):99349.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"236_CR84","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/bjh.15776","volume":"185","author":"RM Ayling","year":"2019","unstructured":"Ayling RM, Lewis SJ, Cotter F. Potential roles of artificial intelligence learning and faecal immunochemical testing for prioritisation of colonoscopy in anaemia. Br J Haematol. 2019;185(2):311\u20136.","journal-title":"Br J Haematol"},{"key":"236_CR85","doi-asserted-by":"crossref","unstructured":"Ayling RM, Wong A, Cotter F. Use of ColonFlag score for prioritisation of endoscopy in colorectal cancer. BMJ Open Gastroenterol. 2021;8(1):e000639.","DOI":"10.1136\/bmjgast-2021-000639"},{"issue":"10","key":"236_CR86","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/cam4.1183","volume":"6","author":"J Birks","year":"2017","unstructured":"Birks J, Bankhead C, Holt TA, Fuller A, Patnick J. Evaluation of a prediction model for colorectal cancer: retrospective analysis of 2.5 million patient records. Cancer Med. 2017;6(10):2453\u201360.","journal-title":"Cancer Med"},{"issue":"7","key":"236_CR87","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1007\/s10620-016-4081-x","volume":"61","author":"B Boursi","year":"2016","unstructured":"Boursi B, Mamtani R, Hwang WT, Haynes K, Yang YX. A Risk Prediction Model for Sporadic CRC Based on Routine Lab Results. Dig Dis Sci. 2016;61(7):2076\u201386.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"236_CR88","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MPA.0000000000002000","volume":"51","author":"B Boursi","year":"2022","unstructured":"Boursi B, Patalon T, Webb M, Margalit O, Beller T, Yang YX, et al. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model; A Retrospective Cohort Study Using Real-World Data. Pancreas. 2022;51(2):196\u20139.","journal-title":"Pancreas"},{"issue":"1","key":"236_CR89","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10620-020-06139-z","volume":"66","author":"W Chen","year":"2021","unstructured":"Chen W, Butler RK, Lustigova E, Chari ST, Wu BU. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model in a Diverse and Integrated Healthcare Setting. Dig Dis Sci. 2021;66(1):78\u201387.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"236_CR90","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.pan.2024.09.015","volume":"24","author":"W Chen","year":"2024","unstructured":"Chen W, Zhou B, Luong TQ, Lustigova E, Xie F, Matrisian LM, et al. Prediction of pancreatic cancer in patients with new onset hyperglycemia: A modified ENDPAC model. Pancreatology. 2024;24(7):1115\u201322.","journal-title":"Pancreatology"},{"issue":"1","key":"236_CR91","doi-asserted-by":"publisher","first-page":"e079863","DOI":"10.1136\/bmjopen-2023-079863","volume":"14","author":"H Claridge","year":"2024","unstructured":"Claridge H, Price CA, Ali R, Cooke EA, de Lusignan S, Harvey-Sullivan A, et al. Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol. BMJ Open. 2024;14(1):e079863.","journal-title":"BMJ Open"},{"key":"236_CR92","first-page":"1","volume":"2","author":"R Goshen","year":"2018","unstructured":"Goshen R, Choman E, Ran A, Muller E, Kariv R, Chodick G, et al. Computer-Assisted Flagging of Individuals at High Risk of Colorectal Cancer in a Large Health Maintenance Organization Using the ColonFlag Test. JCO Clin Cancer Inf. 2018;2:1\u20138.","journal-title":"JCO Clin Cancer Inf"},{"issue":"4","key":"236_CR93","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1164\/rccm.202007-2791OC","volume":"204","author":"MK Gould","year":"2021","unstructured":"Gould MK, Huang BZ, Tammemagi MC, Kinar Y, Shiff R. Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data. Am J Respiratory Crit Care Med. 2021;204(4):445\u201353.","journal-title":"Am J Respiratory Crit Care Med"},{"issue":"6","key":"236_CR94","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/ajcp\/aqab086","volume":"156","author":"RG Hauser","year":"2021","unstructured":"Hauser RG, Esserman D, Beste LA, Ong SY, Colomb DG, Bhargava A, et al. A Machine Learning Model to Successfully Predict Future Diagnosis of Chronic Myelogenous Leukemia With Retrospective Electronic Health Records Data. Am J Clin Pathol. 2021;156(6):1142\u20138.","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"236_CR95","doi-asserted-by":"publisher","first-page":"e0207848","DOI":"10.1371\/journal.pone.0207848","volume":"13","author":"RJ Hilsden","year":"2018","unstructured":"Hilsden RJ, Heitman SJ, Mizrahi B, Narod SA, Goshen R. Prediction of findings at screening colonoscopy using a machine learning algorithm based on complete blood counts (ColonFlag). PLoS ONE. 2018;13(11):e0207848.","journal-title":"PLoS ONE"},{"issue":"10","key":"236_CR96","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s10620-017-4722-8","volume":"62","author":"MC Hornbrook","year":"2017","unstructured":"Hornbrook MC, Goshen R, Choman E, O\u2019Keeffe-Rosetti M, Kinar Y, Liles EG, et al. Early Colorectal Cancer Detected by Machine Learning Model Using Gender, Age, and Complete Blood Count Data. Dig Dis Sci. 2017;62(10):2719\u201327.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"236_CR97","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.pan.2021.02.001","volume":"21","author":"S Khan","year":"2021","unstructured":"Khan S, Safarudin RF, Kupec JT. Validation of the ENDPAC model: Identifying new-onset diabetics at risk of pancreatic cancer. Pancreatology. 2021;21(3):550\u20135.","journal-title":"Pancreatology"},{"issue":"2","key":"236_CR98","doi-asserted-by":"publisher","first-page":"e0171759","DOI":"10.1371\/journal.pone.0171759","volume":"12","author":"Y Kinar","year":"2017","unstructured":"Kinar Y, Akiva P, Choman E, Kariv R, Shalev V, Levin B, et al. Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer. PLoS ONE. 2017;12(2):e0171759.","journal-title":"PLoS ONE"},{"issue":"5","key":"236_CR99","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jamia\/ocv195","volume":"23","author":"Y Kinar","year":"2016","unstructured":"Kinar Y, Kalkstein N, Akiva P, Levin B, Half EE, Goldshtein I, et al. Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study. J Am Med Inform Assoc. 2016;23(5):879\u201390.","journal-title":"J Am Med Inform Assoc"},{"key":"236_CR100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/jgh.13461","volume":"32","author":"S Ng","year":"2017","unstructured":"Ng S, Lam T, Goshen R, Choman E, Muller E, Sagiv T, et al. Validation of the ColonFlag CRC performance in the detection of colorectal cancer in the Hong Kong (HK) population: A retrospective case-control study. J Gastroenterol Hepatol. 2017;32:146.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"236_CR101","first-page":"610","volume":"49","author":"RD Putri","year":"2024","unstructured":"Putri RD, Sujana SA, Hanifa NN, Santoso TA, Abdullah M. Efficacy of ColonFlag as a Complete Blood Count-Based Machine Learning Algorithm for Early Detection of Colorectal Cancer: A Systematic Review. Iran J Med Sci. 2024;49(10):610\u201322.","journal-title":"Iran J Med Sci"},{"key":"236_CR102","doi-asserted-by":"crossref","unstructured":"Read AJ, Zhou W, Saini SD, Zhu J, Waljee AK. Prediction of gastrointestinal tract cancers using longitudinal electronic health record data. Cancers. 2023;15(5):1399.","DOI":"10.3390\/cancers15051399"},{"issue":"12","key":"236_CR103","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1016\/j.cgh.2020.04.054","volume":"18","author":"JL Schneider","year":"2020","unstructured":"Schneider JL, Layefsky E, Udaltsova N, Levin TR, Corley DA. Validation of an Algorithm to Identify Patients at Risk for Colorectal Cancer Based on Laboratory Test and Demographic Data in Diverse, Community-Based Population. Clin Gastroenterol Hepatol. 2020;18(12):2734\u2013e416.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"236_CR104","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","volume":"155","author":"A Sharma","year":"2018","unstructured":"Sharma A, Kandlakunta H, Nagpal SJS, Feng Z, Hoos W, Petersen GM, et al. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. Gastroenterology. 2018;155(3):730\u2013e93.","journal-title":"Gastroenterology"},{"key":"236_CR105","first-page":"159","volume":"17","author":"AS Tarawneh","year":"2024","unstructured":"Tarawneh AS, Al Omari AK, Al-Khlifeh EM, Tarawneh FS, Alghamdi M, Alrowaily MA, et al. Non-Invasive Cancer Detection Using Blood Test and Predictive Modeling Approach. Adv Appl Bioinf Chem AABC. 2024;17:159\u201378.","journal-title":"Adv Appl Bioinf Chem AABC"},{"issue":"19","key":"236_CR106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/cancers14194779","volume":"14","author":"PS Virdee","year":"2022","unstructured":"Virdee PS, Patnick J, Watkinson P, Holt T, Birks J. Full Blood Count Trends for Colorectal Cancer Detection in Primary Care: Development and Validation of a Dynamic Prediction Model. Cancers. 2022;14(19):29.","journal-title":"Cancers"},{"issue":"3","key":"236_CR107","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1097\/MPA.0000000000002295","volume":"53","author":"L Wang","year":"2024","unstructured":"Wang L, Rahimi Larki N, Dobkin J, Salgado S, Ahmad N, Kaplan DE, et al. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With Acute Pancreatitis. Pancreas. 2024;53(3):e254\u20139.","journal-title":"Pancreas"},{"issue":"5","key":"236_CR108","doi-asserted-by":"publisher","first-page":"e0303153","DOI":"10.1371\/journal.pone.0303153","volume":"19","author":"BU Wu","year":"2024","unstructured":"Wu BU, Dong EY, Chen Q, Luong TQ, Lustigova E, Jeon CY, et al. Stomach Cancer Prediction Model (SCoPM): An approach to risk stratification in a diverse U.S. population. PLoS ONE. 2024;19(5):e0303153.","journal-title":"PLoS ONE"},{"key":"236_CR109","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41512-020-00078-z","volume":"4","author":"LM Bull","year":"2020","unstructured":"Bull LM, Lunt M, Martin GP, Hyrich K, Sergeant JC. Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods. Diagn Progn Res. 2020;4:9.","journal-title":"Diagn Progn Res"},{"key":"236_CR110","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12885-015-1424-5","volume":"15","author":"ML Ingeman","year":"2015","unstructured":"Ingeman ML, Christensen MB, Bro F, Knudsen ST, Vedsted P. The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability. BMC Cancer. 2015;15:421.","journal-title":"BMC Cancer"},{"key":"236_CR111","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3399\/bjgp19X700853","volume":"69","author":"N D\u2019Souza","year":"2019","unstructured":"D\u2019Souza N, Brzezicki A, Abulafi M. Faecal immunochemical testing in general practice. Br J Gen Pract. 2019;69:60\u20131.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"236_CR112","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41568-024-00786-4","volume":"25","author":"P Altea-Manzano","year":"2025","unstructured":"Altea-Manzano P, Decker-Farrell A, Janowitz T, Erez A. Metabolic interplays between the tumour and the host shape the tumour macroenvironment. Nat Rev Cancer. 2025;25(4):274\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"236_CR113","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/jamia\/ocaa242","volume":"28","author":"R Sisk","year":"2021","unstructured":"Sisk R, Lin L, Sperrin M, Barrett JK, Tom B, Diaz-Ordaz K, et al. Informative presence and observation in routine health data: A review of methodology for clinical risk prediction. J Am Med Inf Assoc. 2021;28(1):155\u201366.","journal-title":"J Am Med Inf Assoc"},{"key":"236_CR114","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13643-016-0215-7","volume":"5","author":"WM Bramer","year":"2016","unstructured":"Bramer WM, Giustini D, Kramer BM. Comparing the coverage, recall, and precision of searches for 120 systematic reviews in Embase, MEDLINE, and Google Scholar: a prospective study. Syst Rev. 2016;5:39.","journal-title":"Syst Rev"},{"key":"236_CR115","doi-asserted-by":"publisher","first-page":"e70275","DOI":"10.2196\/70275","volume":"11","author":"PS Virdee","year":"2025","unstructured":"Virdee PS, Collins KK, Smith CF, Yang X, Zhu S, Roberts N, et al. Clinical Prediction Models Incorporating Blood Test Trend for Cancer Detection: Systematic Review, Meta-Analysis, and Critical Appraisal. JMIR Cancer. 2025;11:e70275.","journal-title":"JMIR Cancer"}],"container-title":["Diagnostic and Prognostic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41512-026-00236-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41512-026-00236-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41512-026-00236-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:02:04Z","timestamp":1789372924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41512-026-00236-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1186\/s41512-026-00236-9","relation":{},"ISSN":["2397-7523"],"issn-type":[{"value":"2397-7523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24"}}